H. Michael Shepard
2010
In 2010, H. Michael Shepard earned a total compensation of $525.3K as Vice President and Chief Scientific Officer at Halozyme Therapeutics, a 35% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $72,218 |
|---|---|
| Option Awards | $54,031 |
| Salary | $283,836 |
| Other | $115,166 |
| Total | $525,251 |
Shepard received $283.8K in salary, accounting for 54% of the total pay in 2010.
Shepard also received $72.2K in non-equity incentive plan, $54K in option awards and $115.2K in other compensation.
Rankings
In 2010, H. Michael Shepard's compensation ranked 7,517th out of 10,439 executives tracked by ExecPay. In other words, Shepard earned more than 28.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,517 out of 10,439 | 28th |
Division Manufacturing | 2,776 out of 3,838 | 28th |
Major group Chemicals And Allied Products | 665 out of 921 | 28th |
Industry group Drugs | 454 out of 680 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 87 out of 142 | 39th |
Source: SEC filing on April 11, 2013.
Shepard's colleagues
We found seven more compensation records of executives who worked with H. Michael Shepard at Halozyme Therapeutics in 2010.
2010
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2010
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2010
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2010
Jonathan Leff
Halozyme Therapeutics
Chief Medical Officer
2010
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2010
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2010
Michael LaBarre
Halozyme Therapeutics